WHO ICTRP trial

The use of prebiotics and their effect on blood pressure.

ACTRN12619000916145 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12619000916145
Public title The use of prebiotics and their effect on blood pressure.
Scientific title The use of dietary supplements on gut metabolites and their effect on blood pressure in hypertensive patients: a phase IIa clinical trial.
Primary sponsor Dr Francine Marques
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries Australia
Conditions hypertension ;high blood pressure ; hypertension high blood pressure ;Cardiovascular - Hypertension;Metabolic and Endocrine - Other metabolic disorders
Interventions This cross-over trial will test if a modified high fibre food supplement could be used to lower blood pressure. The total study period is 9 weeks, including a 3 week wash-out period between the two arms. -Dose: 40g/day of placebo or fibre…
Registration date Jan 7, 2019
Target size 33
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations